Research Studies
Back to Results
NAtalizumab for Prevention of Post-partum Relapses in patients with Multiple Sclerosis 09May2016
Primary Objective
To assess the efficacy of IV administered natalizumab, monthly for 1 year, in preventing relapses during the postpartum period.
Details
Age
Adult
Phase
IV - Research Studies occurring after FDA has approved a drug for marketing. These studies gather additional information about a drug's safety, efficacy, or optimal use.
Type of Study
Treatment
Location
University of Colorado Hospital
Principal Investigator
Teri Schreiner
Study ID
Protocol Number: 16-0156
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers